News

Cell phone use offers depression diagnostic capability


 

References

Information pulled from cell phone sensor data can provide useful behavioral markers significantly associated with depressive symptom severity, according to Sohrab Saeb, Ph.D., and associates.

The investigators found that several different features pulled from GPS data related to study participants’ depressive symptom severity, including circadian movement, normalized entropy, and location variance. Phone use features, use duration, and use frequency also were related to depressive symptoms, said Dr. Saeb of the center for behavioral intervention technologies in the department of preventive medicine at Northwestern University, Chicago.

©Nick Smith/iStockphoto

The researchers next used the normalized entropy feature and a system separating participants with depressive symptoms (Patient Health Questionnaire [PHQ-9] score greater than or equal to 5) from those without symptoms to identify depressed participants, achieving a success rate of 86.5%. Finally, with the use of normalized entropy data alone to identify the participants’ PHQ-9 scores, an error rate of only 23.5% was achieved.

The study findings “suggest that phone sensors offer numerous clinical opportunities, including continuous monitoring of at-risk populations with little patient burden and interventions that can provide just-in-time outreach,” the investigators concluded.

Find the full study in the Journal of Medical Internet Research (2015 July;17(7):(doi:10.2196/jmir.4273).

lfranki@frontlinemedcom.com

Recommended Reading

School-based CBT program reduces depression, suicidality
MDedge Internal Medicine
Analysis shows link between certain SSRIs and birth defect risk
MDedge Internal Medicine
Adolescent cancer survivors report more emotional, neurocognitive impairment than do siblings
MDedge Internal Medicine
Knowledge lacking on auditory hallucinations in bipolar, depressed patients
MDedge Internal Medicine
Higher cardiorespiratory fitness linked with less depression in middle schoolers
MDedge Internal Medicine
FDA approves Rexulti for schizophrenia, depression in schizophrenia
MDedge Internal Medicine
Adolescents with eating disorders have high rates of psychiatric medication use
MDedge Internal Medicine
Exclusionary guidelines keep many depressed patients out of clinical trials
MDedge Internal Medicine
Vietnam veterans still struggling with PTSD, VA study says
MDedge Internal Medicine
USPSTF recommends depression screening for adults
MDedge Internal Medicine